| Brandt L Esplin, MD | |
|
1055 N 500 W Ste 202, Bldg C, Provo, UT 84604-8460 | |
| (801) 374-2367 | |
| (801) 374-2367 |
| Full Name | Brandt L Esplin |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 13 Years |
| Location | 1055 N 500 W Ste 202, Bldg C, Provo, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285929430 | NPI | - | NPPES |
| P01167837 | Other | MN | RAILROAD MEDICARE |
| ENROLLED | Medicaid | IA | |
| ENROLLED | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 10204311-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Castleview Hospital | Price, UT | Hospital |
| Sevier Valley Hospital | Richfield, UT | Hospital |
| Sanpete Valley Hospital - Cah | Mount pleasant, UT | Hospital |
| Utah Valley Hospital | Provo, UT | Hospital |
| Gunnison Valley Hospital | Gunnison, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Utah Clinic Pc | 7517868508 | 391 |
News Archive
Researchers at University of Colorado School of Medicine may have figured out what causes Meniere's disease and how to attack it. According to Carol Foster, MD, from the department of otolaryngology and Robert Breeze, MD, a neurosurgeon, there is a strong association between Meniere's disease and conditions involving temporary low blood flow in the brain such as migraine headaches.
The American College of Surgeons Stop the Bleed program announced today that it has now surpassed the 1 million mark in terms of the number of people who have been trained to control major bleeding through its Stop the Bleed course.
Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of products in the areas of topical pain and immunology, and NovaMedica LLC, a Russian pharmaceutical company, today announced that they have signed a supply and distribution agreement providing NovaMedica the exclusive rights to market and sell Nuvo's Pennsaid 1.5% and Pennsaid 2% products in Russia and some of the Community of Independent States.
Treating advanced melanoma patients with either a combination of the immunotherapy drugs nivolumab (Opdivo™) and ipilimumab (Yervoy™) or nivolumab alone significantly increases progression-free survival (PFS) over using ipilimumab alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) simultaneously presented today at the American Society of Clinical Oncology (ASCO) annual meeting and published online in the New England Journal of Medicine (NEJM). Examining specific characteristics of each patient's tumor has also given researchers clearer understanding of which patients should receive the combination.
Conservation of tropical peatlands could reduce the impacts of the COVID-19 pandemic and the likelihood of new diseases jumping from animals to humans, researchers say.
› Verified 1 days ago
| Entity Name | Central Utah Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093764805 PECOS PAC ID: 7517868508 Enrollment ID: O20040113000805 |
News Archive
Researchers at University of Colorado School of Medicine may have figured out what causes Meniere's disease and how to attack it. According to Carol Foster, MD, from the department of otolaryngology and Robert Breeze, MD, a neurosurgeon, there is a strong association between Meniere's disease and conditions involving temporary low blood flow in the brain such as migraine headaches.
The American College of Surgeons Stop the Bleed program announced today that it has now surpassed the 1 million mark in terms of the number of people who have been trained to control major bleeding through its Stop the Bleed course.
Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of products in the areas of topical pain and immunology, and NovaMedica LLC, a Russian pharmaceutical company, today announced that they have signed a supply and distribution agreement providing NovaMedica the exclusive rights to market and sell Nuvo's Pennsaid 1.5% and Pennsaid 2% products in Russia and some of the Community of Independent States.
Treating advanced melanoma patients with either a combination of the immunotherapy drugs nivolumab (Opdivo™) and ipilimumab (Yervoy™) or nivolumab alone significantly increases progression-free survival (PFS) over using ipilimumab alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) simultaneously presented today at the American Society of Clinical Oncology (ASCO) annual meeting and published online in the New England Journal of Medicine (NEJM). Examining specific characteristics of each patient's tumor has also given researchers clearer understanding of which patients should receive the combination.
Conservation of tropical peatlands could reduce the impacts of the COVID-19 pandemic and the likelihood of new diseases jumping from animals to humans, researchers say.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brandt L Esplin, MD 1055 N 500 W Attn: Credentialing, Provo, UT 84604 Ph: (801) 354-8225 | Brandt L Esplin, MD 1055 N 500 W Ste 202, Bldg C, Provo, UT 84604-8460 Ph: (801) 374-2367 |
News Archive
Researchers at University of Colorado School of Medicine may have figured out what causes Meniere's disease and how to attack it. According to Carol Foster, MD, from the department of otolaryngology and Robert Breeze, MD, a neurosurgeon, there is a strong association between Meniere's disease and conditions involving temporary low blood flow in the brain such as migraine headaches.
The American College of Surgeons Stop the Bleed program announced today that it has now surpassed the 1 million mark in terms of the number of people who have been trained to control major bleeding through its Stop the Bleed course.
Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of products in the areas of topical pain and immunology, and NovaMedica LLC, a Russian pharmaceutical company, today announced that they have signed a supply and distribution agreement providing NovaMedica the exclusive rights to market and sell Nuvo's Pennsaid 1.5% and Pennsaid 2% products in Russia and some of the Community of Independent States.
Treating advanced melanoma patients with either a combination of the immunotherapy drugs nivolumab (Opdivo™) and ipilimumab (Yervoy™) or nivolumab alone significantly increases progression-free survival (PFS) over using ipilimumab alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) simultaneously presented today at the American Society of Clinical Oncology (ASCO) annual meeting and published online in the New England Journal of Medicine (NEJM). Examining specific characteristics of each patient's tumor has also given researchers clearer understanding of which patients should receive the combination.
Conservation of tropical peatlands could reduce the impacts of the COVID-19 pandemic and the likelihood of new diseases jumping from animals to humans, researchers say.
› Verified 1 days ago
Dr. Christopher Gordon, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 745 N 500 W Ste 200, Provo, UT 84601 Phone: 801-375-9292 Fax: 801-375-9290 | |
Daniel N. Bennett, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 500 W, Ste 101, Building C, Provo, UT 84604 Phone: 801-373-4366 | |
Dr. Christopher Ryan Lew, DO Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-960-7558 | |
Albert Rivero, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1134 N 500 W Ste 101, Provo, UT 84604 Phone: 801-357-8310 | |
Dr. Wenshu Yu, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3650 N University Ave Ste 150, Provo, UT 84604 Phone: 801-818-1940 Fax: 801-818-1945 | |
William T. Stephenson Ii, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 395 W Bulldog Blvd Ste 103, Provo, UT 84604 Phone: 801-357-8200 Fax: 801-357-8201 | |
Gregory E Craner, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1055 N 500 W, Suite 100 Bldg B, Provo, UT 84604 Phone: 801-374-1268 Fax: 801-429-8041 |